ADMINISTRATION The Consortium Administration provides high quality, efficient, and effective support to Fred Hutch/University of Washington Cancer Consortium leaders, Research Programs, Shared Resources, and members. Administration owns and drives the processes that Consortium scientific leaders use to define the Consortium's vision and strategic goals, implement initiatives, monitor progress in achieving objectives, and secure needed resources to develop and maintain the requisite infrastructure. Consortium Director Dr. Gary Gilliland and senior leaders developed a strategic plan through a process started when he arrived in 2015. The process is ongoing by design with annual internal and external evaluations of milestones. Throughout the process Administration ensures that CCSG guidelines are integral to the strategic goals and activities. As a result of these activities, Consortium membership has grown by >170 members; cancer-relevant grant funding for the Consortium is at $242M, of which $50M is from the NCI; interventional trials have 5,424 accruals and non-interventional trials have 5,292 accruals (increases of 83% and 20%, respectively, from FY 2014 to FY 2018); and members have over 6,600 cancer-related publications as authors and co-authors, with 11% of them in journals with impact factors greater than 20. New in this cycle of the CCSG are the components for Community Outreach & Engagement (COE) and Cancer Research Career Enhancement (CRCE). Administration has been pivotal to establishing offices for both of these new components to oversee their respective areas of activity. Other new Consortium initiatives include the formation of three Integrated Research Centers (IRCs), the continued development of the Seattle Translational Tumor Research initiative (STTR), and major enhancements of clinical trials infrastructure. Administration has interfaced with initiative leaders and their respective administrators in order to leverage strengths and resources toward supporting Research Programs and members. Finally, as a result of faculty feedback, a new developing Shared Resource for preclinical mouse models was developed by Administration to further Consortium science. `

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA015704-45
Application #
9853645
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-01-01
Budget End
2020-12-31
Support Year
45
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Jeong, Kyoung Sook; Zhou, Jin; Griffin, Stephanie C et al. (2018) MicroRNA Changes in Firefighters. J Occup Environ Med 60:469-474
Appelbaum, Jacob; Wells, David; Hiatt, Joseph B et al. (2018) Fatal enteric plexus neuropathy after one dose of ipilimumab plus nivolumab: a case report. J Immunother Cancer 6:82
Blair, Kris M; Mears, Kevin S; Taylor, Jennifer A et al. (2018) The Helicobacter pylori cell shape promoting protein Csd5 interacts with the cell wall, MurF, and the bacterial cytoskeleton. Mol Microbiol 110:114-127
Talarico, Sarah; Korson, Andrew S; Leverich, Christina K et al. (2018) High prevalence of Helicobacter pylori clarithromycin resistance mutations among Seattle patients measured by droplet digital PCR. Helicobacter 23:e12472
Bhatia, Shailender; Miller, Natalie J; Lu, Hailing et al. (2018) Intratumoral G100, a TLR4 Agonist, Induces Antitumor Immune Responses and Tumor Regression in Patients with Merkel Cell Carcinoma. Clin Cancer Res :
Chozinski, Tyler J; Mao, Chenyi; Halpern, Aaron R et al. (2018) Volumetric, Nanoscale Optical Imaging of Mouse and Human Kidney via Expansion Microscopy. Sci Rep 8:10396
Holly, Mayumi K; Smith, Jason G (2018) Adenovirus infection of human enteroids reveals interferon sensitivity and preferential infection of goblet cells. J Virol :
Cheng, Heather H (2018) The resounding effect of DNA repair deficiency in prostate cancer. Urol Oncol 36:385-388
Poudel, Kumud R; Roh-Johnson, Minna; Su, Allen et al. (2018) Competition between TIAM1 and Membranes Balances Endophilin A3 Activity in Cancer Metastasis. Dev Cell 45:738-752.e6
Eaton, Keith D; Romine, Perrin E; Goodman, Gary E et al. (2018) Inflammatory Gene Polymorphisms in Lung Cancer Susceptibility. J Thorac Oncol 13:649-659

Showing the most recent 10 out of 1267 publications